Cite Filings / IMVT / 0001764013-25-000104

Feed Companies Filings Check

Sign in

DEFA14A

Proxy Materials

Immunovant, Inc. Filed 2025-07-09 Acc 0001764013-25-000104

Documents 1

DEFA14A Proxy Materials , defa14aadditionalmaterials.htm

Around this filing

2026-07-22 DEFA14A Proxy Materials
2025-07-11 4 Chief Medical Officer sold 1,160 shares at $17.24 ($19,998)
2025-07-11 4 Chief Technology Officer sold 1,519 shares at $17.24 ($26,188)
2025-07-09 ARS Annual Report to Security Holders
2025-07-09 DEFA14A Proxy Materials
2025-07-09 DEF 14A Proxy Statement
2024-06-26 DEFA14A Proxy Materials

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading defa14aadditionalmaterials.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…